Sign In
Buy SGEN
$228.74
+0 (+0%)
At Close: Mar 12, 2024
Seagen Inc. (SGEN) CEO Clay Siegall on Q1 2022 Results - Earnings Call Transcript
06:51pm, Thursday, 28'th Apr 2022
Seagen Inc. (NASDAQ:SGEN ) Q1 2022 Earnings Conference Call April 28, 2022 4:30 PM ET Company Participants Peggy Pinkston - Senior Vice President of Investor Relations Clay Siegall - President & Chief
Analysts Estimate Seattle Genetics (SGEN) to Report a Decline in Earnings: What to Look Out for
07:01pm, Thursday, 21'st Apr 2022 Zacks Investment Research
Seattle Genetics (SGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Biotech giant Seagen reveals plans for 270K square-foot manufacturing facility near Seattle
01:43pm, Wednesday, 20'th Apr 2022
Seagen is expanding its manufacturing capacity in the Seattle area.
3 Risky Stocks With Huge Potential Upside
03:00pm, Friday, 15'th Apr 2022 The Motley Fool
Why risk-tolerant investors want to own Shopify, Silvergate Capital, and Pieris Pharmaceuticals.
Seagen (SGEN) Gets Nod From EU for Bladder Cancer Drug, Padcev
02:59pm, Thursday, 14'th Apr 2022 Zacks Investment Research
The European Commission approves Seagen's (SGEN) Padcev as a monotherapy for treating adult patients with locally advanced/metastatic urothelial cancer.
Genmab (GMAB), AbbVie's Epcoritamab Successful in LBCL Study
02:01pm, Thursday, 14'th Apr 2022 Zacks Investment Research
Genmab (GMAB) and AbbVie are co-developing epcoritamab as a potential treatment for hematologic malignancies including NHL and LBCL. A phase I/II study evaluating it in LBCL achieves a response rate o
Seagen (SGEN) Gets Nod From EU for Bladder Cancer Drug, Padcev
12:03pm, Thursday, 14'th Apr 2022
The European Commission approves Seagen's (SGEN) Padcev as a monotherapy for treating adult patients with locally advanced/metastatic urothelial cancer.
4 'Double Discounted' CEFs Yielding Up To 9.1%
09:08am, Thursday, 14'th Apr 2022 Investing.comTop Stocks To Buy This Week
01:33pm, Tuesday, 12'th Apr 2022
We've crunched the data to bring you the best and boldest Top Stocks from last week's winners and losers.
Company News for Apr 12, 2022
01:04pm, Tuesday, 12'th Apr 2022 Zacks Investment Research
Companies In The News Are: TWTR, SGEN, T, LUV
Here's Why Bicycle Therapeutics Stock Looks Ill Today
03:57pm, Monday, 11'th Apr 2022 The Motley Fool
Lackluster clinical trial results for its lead candidate are to blame.
3 Healthcare Stocks That Could Help Set You Up for Life
03:15pm, Thursday, 07'th Apr 2022 The Motley Fool
These stocks are full of growth potential.
Trading The Top 10 Stocks From 40 Large Hedge Funds: Trading Update 4/3/2022
04:04am, Monday, 04'th Apr 2022 Seeking Alpha
This portfolio strategy uses the quarterly 13F filings to extract 50 consensus stocks from 40 large hedge funds that have more than $3.5 billion AUM.
9 Wave Setups To Watch (Video)
12:41pm, Friday, 01'st Apr 2022
Some of these stocks present long opportunities as they pull back.
Tekla Healthcare Investors: A Dividend Paymaster That Can Compensate For Poor Price Performance
11:31pm, Tuesday, 29'th Mar 2022
Tekla Healthcare Investors: A Dividend Paymaster That Can Compensate For Poor Price Performance
